The most common biomarkers of Alzheimer’s disease (AD) are amyloid β (Aβ) and tau, detected in cerebrospinal fluid (CSF) or with positron emission tomography imaging. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.